U.S. Markets closed

Immunomedics, Inc. (IMMU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.72+0.25 (+3.35%)
At close: 4:00PM EDT
People also watch
Interactive chart
Previous Close7.47
Bid7.72 x 500
Ask8.25 x 200
Day's Range7.31 - 7.97
52 Week Range1.95 - 7.97
Avg. Volume3,411,588
Market Cap846.14M
PE Ratio (TTM)-6.72
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com2 days ago

    Biotech Movers: Immunomedics, Aerie, Exelixis

    Immunomedics, Aerie Pharmaceuticals and Exelixis were among the biotech movers in premarket trading on Friday.

  • Capital Cube3 days ago

    ETFs with exposure to Immunomedics, Inc. : May 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Immunomedics, Inc. Here are 5 ETFs with the largest exposure to IMMU-US. Comparing the performance and risk of Immunomedics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017
    Capital Cube4 days ago

    Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Immunomedics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Immunomedics, Inc. – Seattle Genetics, Inc., Navidea Biopharmaceuticals, Inc., Pfizer Inc., Anthera Pharmaceuticals, Inc., Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company and Eli Lilly and Company (SGEN-US, NAVB-US, PFE-US, ... Read more (Read more...)